A new research study has shed light on potential side effects of GLP-1 drugs, including Wegovy and Ozempic. According to a ...
--Amgen today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia ® injection reduced fracture ...
Can an augmented health care delivery pathway reduce the chances of those future fractures and improve outcomes that are important to patients? Two University of Alabama at Birmingham researchers have ...
Positive topline results demonstrate clinical similarity between AVT03 and the reference biologic, Prolia® (denosumab) Two additional studies comparing the pharmacokinetics, safety, and tolerability ...
My mother also had osteoporosis.
Many women on dialysis quickly developed severe hypocalcemia after starting denosumab (Prolia) for osteoporosis, Medicare data showed. During the first 12 weeks of treatment, 41.1% of women on ...
Osteoporosis is a degenerative, debilitating bone disease that is increasingly prevalent in postmenopausal women. Despite its being classified as one of the four most dangerous health issues today, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results